Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

1.50
Delayed Data
As of Dec 07
 +0.05 / +3.45%
Today’s Change
1.10
Today|||52-Week Range
3.38
-54.55%
Year-to-Date

Today’s Trading

Previous close1.45
Today’s open1.65
Day’s range1.50 - 1.68
Volume157,981
Average volume (3 months)118,202
Market cap$27.4M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-8.89%
Earnings growth (this year)+41.58%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+76.87%
P/E ratioNM
Price/Sales1.88
Price/Book0.60

Competitors

 Today’s
change
Today’s
% change
GALTGalectin Therapeutic...-0.00-0.05%
BMRABiomerica Inc0.000.00%
APPYVenaxis Inc-0.01-0.24%
APHBAmpliPhi Biosciences...+0.04+8.51%
Data as of 3:59pm ET, 12/07/2016

Financials

Next reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$18.0M
Annual profit (last year)-$20.2M
Net profit margin-111.88%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Chief Operating Officer &
EVP-Finance
John A. Roberts
Corporate headquarters
Rutherford, New Jersey

Forecasts


Search for Jobs